Your cart is currently empty!

Atomfair Atabecestat JNJ-54861911 C18H14FN5OS
Description Atabecestat (CAS No. 1200493-78-2) is a high-purity small molecule inhibitor with the molecular formula C18H14FN5OS. This compound, also known by its IUPAC name N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide , is a selective beta-secretase (BACE1) inhibitor extensively studied for its potential therapeutic applications in neurodegenerative disorders. Atabecestat is supplied as a lyophilized powder with ??98% purity (HPLC) and is rigorously characterized by1H NMR, LC-MS, and elemental analysis to ensure batch-to-batch consistency. The product is packaged under inert gas in amber glass vials to ensure long-term stability and is suitable for in vitro and in vivo research applications. Store at -20??C under nitrogen atmosphere for…
Description
Description
Atabecestat (CAS No. 1200493-78-2) is a high-purity small molecule inhibitor with the molecular formula C18H14FN5OS. This compound, also known by its IUPAC name N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide, is a selective beta-secretase (BACE1) inhibitor extensively studied for its potential therapeutic applications in neurodegenerative disorders. Atabecestat is supplied as a lyophilized powder with ??98% purity (HPLC) and is rigorously characterized by 1H NMR, LC-MS, and elemental analysis to ensure batch-to-batch consistency. The product is packaged under inert gas in amber glass vials to ensure long-term stability and is suitable for in vitro and in vivo research applications. Store at -20??C under nitrogen atmosphere for optimal stability.
- CAS No: 1200493-78-2
- Molecular Formula: C18H14FN5OS
- Molecular Weight: 367.4
- Exact Mass: 367.09030942
- Monoisotopic Mass: 367.09030942
- IUPAC Name: N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
- SMILES: C[C@]1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
- Synonyms: Atabecestat, 1200493-78-2, JNJ-54861911, Atabecestat [INN], Atabecestat [USAN]
Application
Atabecestat is a potent and selective beta-secretase (BACE1) inhibitor developed for Alzheimer’s disease research. It demonstrates high blood-brain barrier permeability in preclinical models, making it valuable for studying amyloid-beta plaque reduction. The compound has been investigated in clinical trials for its potential to slow cognitive decline by inhibiting A?? peptide production.
If you are interested or have any questions, please contact us at support@atomfair.com